Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Treasury Shares (2019 - 2025)

Historic Treasury Shares for OptimizeRx (OPRX) over the last 4 years, with Q3 2025 value amounting to $2000.0.

  • OptimizeRx's Treasury Shares changed 0.0% to $2000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $2000.0 for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, OptimizeRx's Treasury Shares is $1.7 million, which was down 0.0% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Treasury Shares registered a high of $1.7 million during Q1 2023, and its lowest value of -$693246.0 during Q3 2022.
  • Moreover, its 5-year median value for Treasury Shares was $1.7 million (2023), whereas its average is $1.2 million.
  • In the last 5 years, OptimizeRx's Treasury Shares skyrocketed by 1329230.77% in 2023 and then changed by 0.0% in 2024.
  • OptimizeRx's Treasury Shares (Quarter) stood at $1214.0 in 2022, then skyrocketed by 64.74% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
  • Its Treasury Shares stands at $2000.0 for Q3 2025, versus $2000.0 for Q2 2025 and $2000.0 for Q1 2025.